 | Up a level |
Jump to: Journal Article
Number of items: 1.
Journal Article
Lesmeister, L. M., Peitz, J., von Kleist-Retzow, J. C., Lee-Kirsch, M. A., Torrelo, A., Tantcheva-Poor, I. and Broekaert, I. J. (2022). Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum. J. Eur. Acad. Dermatol. Venereol., 36 (5). S. E376 - 3. HOBOKEN: WILEY. ISSN 1468-3083